Cyclo-oxygenase-2 in vascular smooth muscle

Area of Science:

• Vascular Biology
• Inflammation Research
• Molecular Medicine

Background:

• Two cyclo-oxygenase (COX) isoforms exist: COX-1 (constitutive) and COX-2 (inducible).
• COX metabolites influence vascular smooth muscle cell (VSMC) function and vascular interactions.
• The role of COX-2 in human arterial and venous VSMC function is under investigation.

Purpose of the Study:

• To investigate COX-2 induction and regulation in human arterial and venous smooth muscle cells.
• To explore the functional consequences of COX-2 activity on VSMC responses.
• To compare COX-2 expression and prostanoid release between arterial and venous smooth muscle cells.

Main Methods:

• Induction of COX-2 in freshly isolated human vessels in culture.
• Stimulation with pro-inflammatory cytokines.
• Measurement of prostanoid release and COX-2 protein expression.
• Analysis of VSMC proliferation, adhesion, and mediator release.

Main Results:

• COX-2 can be induced in human arterial and venous smooth muscle cells, further enhanced by cytokines.
• Saphenous vein smooth muscle cells exhibit significantly higher prostanoid release and COX-2 protein levels compared to internal mammary artery cells.
• An arterial cell-specific negative feedback mechanism likely accounts for the observed differences.
• Cytokines also regulate VSMC proliferation, adhesion, and mediator release, with COX-2 activity influencing these responses.

Conclusions:

• COX-2 is an inducible regulator of human vascular smooth muscle cell function.
• Differences in COX-2 induction and prostanoid production exist between venous and arterial smooth muscle cells.
• Understanding COX-2's role in VSMC is crucial for addressing vascular inflammation and disease.